NCORP Annual Meeting (Registration)

Submitted by chamorroh on

Registration

This meeting is not open to the public; it is for NCORP grantees and pertinent NCI staff participation only. 

The NCORP Annual Meeting will be an in-person meeting. In-Person Registration Deadline is Monday, August 18, 2025.  

Virtual registration will remain open through Tuesday, August   26, 2025. 

 

Contact Information
NIH Employee:
NCORP Affiliation
NCORP Role
Attendance
Please select how you plan to attend the NCORP Annual Meeting:
Is this your first NCORP meeting?
Are you a NIH Badge Holder, U.S. Citizen, or Permanent Resident with a green card

Attention: Visitors who are not NIH Badge Holders, U.S. Citizens or Permanent Residents with a green card must submit documentation of a U.S. Visa or Visa Waiver Program at least 30 days prior to their visit to the NIH/NCI facility. You will receive an email with instructions shortly after submission of this form. Please be advised that failure to submit the required form at least 30 days before your scheduled arrival may result in denial of entry to the NCI/NIH campus.

Breakout Sessions

During the meeting you will have an opportunity to participate in the breakout sessions. Breakouts will be held concurrently, so you may only select one per session. 

Click the view description link below the title to read more about each breakout session.

More
This session will focus on strengthening cancer care delivery research (CCDR) within the NCORP network, emphasizing the unique opportunities and challenges of conducting CCDR studies in the community setting. Participants will explore key barriers in implementing unique study designs, including aligning research with clinical workflows and ensuring equitable participation. Attendees will collaborate to share experiences, identify best practices, and inform future CCDR studies.
More
This session will explore practical tools and strategies we can use to strengthen cancer screening efforts within the NCORP network. In this session, participants will engage in discussions around best practices and innovative approaches to identify and screen different populations. Data from DCP-001, "Use of a Clinical Trial Screening Tool to Address Barriers to Clinical Trial Accrual in the NCI Community Oncology Research Program (NCORP)” will be shared to enhance our understanding of patient- and trial-related barriers to enrollment by trial type (e.g., treatment, symptom management, prevention).
More
This interactive breakout session will solicit attendee input regarding the addition of questions to the NCORP landscape survey about site capacity for screening/prevention studies. This session will also ask for attendee feedback on what they feel are key operational challenges for implementing prevention studies at their sites or within the network.  
More
This interactive breakout session is designed to tap into the collective wisdom of our NCORP network. This session will offer a supportive, solutions-focused space where attendees can bring real-world operational challenges, they’re facing for peer input and feedback. Topics will include navigating limited staffing, managing regulatory bottlenecks, and fine-tuning quality assurance and data monitoring practices. Come prepared with challenges from your site that you might want to share with your colleagues.

Click the view description link below the title to read more about each breakout session.

More
NCORP continues to expand the AYA trial portfolio with two new protocols opening later this year. This breakout session will focus on the NCORP AYA portfolio and the unique challenges and opportunities in reaching adolescents and young adults and how improve their participation in NCORP trials. This interactive session aims to foster collaboration among NCORP staff to share best practices, discuss feasibility of AYA protocols at their NCORP site, and identify strategies to overcome barriers to AYA accrual.
More
This session will explore practical tools and strategies we can use to strengthen cancer screening efforts within the NCORP network. In this session, participants will engage in discussions around best practices and innovative approaches to identify and screen different populations. Data from DCP-001, "Use of a Clinical Trial Screening Tool to Address Barriers to Clinical Trial Accrual in the NCI Community Oncology Research Program (NCORP)” will be shared to enhance our understanding of patient- and trial-related barriers to enrollment by trial type (e.g., treatment, symptom management, prevention).
More
This interactive breakout session is designed to tap into the collective wisdom of our NCORP network. This session will offer a supportive, solutions-focused space where attendees can bring real-world operational challenges, they’re facing for peer input and feedback. Topics will include navigating limited staffing, managing regulatory bottlenecks, and fine-tuning quality assurance and data monitoring practices. Come prepared with challenges from your site that you might want to share with your colleagues.
More
This breakout session will focus on reviewing NCORP’s portfolio of work in symptom management. We will compare the current portfolio to the steering committee’s priority areas and discuss potential new priorities as we move forward. These breakout conversations will also focus on exploring key barriers to study design and implementation of symptom management research protocols within NCORP. We encourage both the Symptom Science Steering Committee members and NCORP PIs to attend to help identify symptom science priorities at their respective community sites.

Breakout sessions will be held August 25, 2025 from 1 PM to 4 PM ET and will only be available to those who attend in person.

Special Accommodations

Special Accommodations 

If you require assistive services or other reasonable accommodations (nursing room, interpretation, CART service, etc.) to participate in this meeting, please list them below or email Ms. Mela Asefa at mela.asefa@nih.gov to discuss your needs. Please notify Ms. Asefa at least 10 days before the meeting.